Does RUXOLITINIB Cause Transferrin saturation increased? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Transferrin saturation increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
7
Reports of Transferrin saturation increased with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Transferrin saturation increased From RUXOLITINIB?
Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization.
Is Transferrin saturation increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Transferrin saturation increased?
TETRAFERRIC TRICITRATE DECAHYDRATE (169)
FERRIC OXYHYDROXIDE (14)
SUCROFERRIC OXYHYDROXIDE (9)
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (8)
SEVELAMER (8)
IRON SUCROSE (7)
ECULIZUMAB (5)
LEVOTHYROXINE (5)
Which RUXOLITINIB Alternatives Have Lower Transferrin saturation increased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE